Stock listing
CADL Stock Price, News, Filings & Events — Candel Therapeutics, Inc.
Selected listing: CADL · BOATS · USD · US
This page tracks Candel Therapeutics, Inc.'s CADL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CADL:BOATS. CADL:BOATS is the stock-level entry point for investors researching Candel Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Candel Therapeutics, Inc. (ticker: CADL) is a public company operating in the American market, with a market capitalization of approximately $700.5 million. The company focuses on developing innovative therapies for cancer treatment. Candel is committed to advancing its pipeline of therapeutics to improve patient outcomes.

- Ticker
- CADL:BOATS
- Asset type
- Stock
- Market cap
- $806.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Candel Therapeutics, Inc. CADL:BOATS stock context
This page tracks Candel Therapeutics, Inc.'s CADL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CADL:BOATS. CADL:BOATS is the stock-level entry point for investors researching Candel Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Candel Therapeutics, Inc. (ticker: CADL) is a public company operating in the American market, with a market capitalization of approximately $700.5 million. The company focuses on developing innovative therapies for cancer treatment. Candel is committed to advancing its pipeline of therapeutics to improve patient outcomes.
Latest news from Candel Therapeutics, Inc.
Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
September 10, 2026
Candel Therapeutics to Present at September Investor Conferences
August 26, 2026
Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 13, 2026
Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026
August 3, 2026
Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
July 29, 2026
Research Candel Therapeutics, Inc.
Candel Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for CADL:BOATS.
Candel Therapeutics, Inc. company profile
View the public company page for Candel Therapeutics, Inc. on 6ix.
Candel Therapeutics, Inc. news
Read company news and market updates connected to Candel Therapeutics, Inc..
Candel Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Candel Therapeutics, Inc..